The retinoblastoma tumour suppressor in development and cancer
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Since its discovery, the retinoblastoma (RB) tumour-suppressor protein has been a focal point of cancer research. Accumulating evidence indicates a complex role for RB in cell proliferation, differentiation and survival. To further complicate matters, proteins that are related to RB have redundant as well as antagonistic functions. Recent studies of knockout mice and cells that lack one or more of these proteins have begun to clarify their various context-specific functions and the unique activity of this tumour suppressor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The role of RB in promoting cellular differentiation during embryonic development and in adult lineages has been well characterized in mutant mice and in vitro systems20,42,58–61.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [61]
In the citing paper
“The growth suppressive properties of Rb are largely, but not completely, associated with its binding to the transcription factor E2F and repressing transcription at target promoters (Classon and Harlow, 2002; Harbour and Dean, 2000; Stevaux and Dyson, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
In the citing paper
“In virtually all human cancer cells, this circuit is dysregulated by either overexpression of cyclin D1, loss of p16Ink4a, the mutation of CDK4 to an Ink4-refractory state, or the loss of Rb itself (Classon and Harlow, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“RB is therefore linked directly to the intricate regulatory network that controls cell-cycle progressio”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459 · cited 1×
“These findings indicated that RB is a regulator of cell proliferatio”
BackgroundHuman Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Self-citationMice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Research works printed but not linked: 4
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. W. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Vooijs, M. & Berns, A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293–5303 (1999). · DOI
- Elliott, M. J., Dong, Y. B., Yang, H. & McMasters, K. M. E2F-1 upregulates c-Myc and p14ARF and induces apoptosis in colon cancer cells. Clin. Cancer Res. 7, 3590–3597 (2001).
Cited by
Items 501–600 of 738
Genotipagem de Papiloma Vírus Humano em paciente com papilomatose laríngea recorrente
Silva, A. M. T. C., da Cruz, A. D., da Silva, C. C., Borges, F. R., & Curado, M. P. (2003) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2003v49n3.2093 · Cited by 9
Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model
Tarang, S., Doi, S. M. D. S. R., Gurumurthy, C. B., Harms, D. W., Quadros, R. M., & Rocha-Sanchez, S. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00052 · Cited by 12
“ORIGINAL RESEARCH ARTICLE published: 23 February 2015 doi: 10.3389/fncel.2015.00052 Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model”
InfluentialGuo, X., Hutcheon, A. E. K., & Zieske, J. D. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1164 · Cited by 9
Zhang, H., Jin, L. I., Wang, Y., Meng, A., Liu, Q., Wang, L., Chen, F., Wang, X., Zhai, Z., Yue, F. U., et al. (2012) · Journal of Radiation Research · doi:10.1269/jrr.11051 · Cited by 9
Tominaga, K., Magee, D. M., Matzuk, M. M., & Pereira‐Smith, O. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8366-8373.2004 · Cited by 10
Protein phosphatase 1α is required for murine lung growth and morphogenesis
Hormi‐Carver, K., Shi, W., Liu, C. W. Y., & Berndt, N. (2004) · Developmental Dynamics · doi:10.1002/dvdy.10497 · Cited by 9
“…cycle regulators (Zhang, 1999; Duronio, 1999; Vidwans and Su, 2001), including the pRb tumor suppressor (Lipinski and Jacks, 1999; MacLeod, 1999; Classon and Harlow, 2002), regulators of apoptosis (Vaux and Korsmeyer, 1999; Meier et al., 2000), and cell size (Conlon and Raff, 1999; Kozma and…”
BackgroundNovel insights into RB1 in prostate cancer lineage plasticity and drug resistance
Ma, M., Zhu, Y., Xiao, C., Li, R., Cao, X., Kang, R., Wang, X., & Li, E. (2024) · Tumori Journal · doi:10.1177/03008916231225576 · Cited by 10
Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities
Hwang, Y.-J., & Kim, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010322 · Cited by 12
Cdk6: At the interface of Rb and p53
Nebenfuehr, S., Bellutti, F., & Sexl, V. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1511206 · Cited by 8
“The CDK4/6-Cyclin D complexes phosphorylate members of the retinoblastoma (RB) protein family thereby releasing E2F transcription factors from RB-mediated inhibition.(1) In cancer the activity of CDK4- and CDK6-Cyclin complexes are frequently altered with enhanced CDK6 expression being common in hematopoietic malignan…”
BackgroundSmall Molecular Immune Modulators as Anticancer Agents
Han, Y., Zhu, L., Wu, W., Zhang, H., Hu, W., Dai, L., & Yang, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_22 · Cited by 8
Sen, T., Chen, J., & Singbrant, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-96585-0 · Cited by 10
Alteration to the SWI/SNF complex in human cancers
Gordon, V. S., Rogers, C., & Reisman, D. (2010) · Oncology Reviews · doi:10.1007/s12156-010-0040-5 · Cited by 10
“These observations are significant, as p107 and p130 are rarely mutated in tumors [96, 97 ], suggesting that BRM reexpression may result in growth inhibition in the major tumors deficient in their expression.”
BackgroundRbf1 degron dysfunction enhances cellular DNA replication
Raj, N., Zhang, L. N., Wei, Y., Arnosti, D. N., & Henry, R. W. (2012) · Cell Cycle · doi:10.4161/cc.21665 · Cited by 9
Retinoblastoma and tumor-suppressor gene therapy
Xu, H. E. (2003) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(03)00065-8 · Cited by 9
“The functional aspects of the RB gene and the pRBs have been reviewed frequently [19–22].”
BackgroundE2F-1 as an anticancer drug target
Bertino, J. R., & Banerjee, D. (2009) · Oncology Reviews · doi:10.1007/s12156-009-0028-1 · Cited by 7
Curcumin: Structure, Biology and Clinical Applications
Shankar, S., & Srivastava, R. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-2923-0_17 · Cited by 9
“The retinoblastoma tumor suppressor protein (pRB) is a negative regulator of cell proliferation (Classon and Harlow 2002).”
BackgroundE2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression
Palacios, G. F., Talos, F., Nemajerová, A., Moll, U. M., & Petrenko, O. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6030 · Cited by 8
Novel p53/p130 Axis in Bladder Tumors
Mudryj, M. M., Reay, E., Beckett, L. A., Dandekar, S., White, R. D., & Gandour‐Edwards, R. F. (2007) · Urology · doi:10.1016/j.urology.2007.05.002 · Cited by 7
Dick, F. A., & Mymryk, J. S. (2011) · Genes & Development · doi:10.1101/gad.2050411 · Cited by 10
“Both pathways are well known to regulate proliferation in development, and mutations that affect their integrity contribute to cancer (Classon and Harlow 2002; Pan 2010).”
Backgroundp16INK4A-independence of Epstein–Barr virus-induced cell proliferation and virus latency
Hayes, M. J., Koundouris, A., Gruis, N. A., Bergman, W., Peters, G. G., & Sinclair, A. J. (2004) · Journal of General Virology · doi:10.1099/vir.0.79831-0 · Cited by 8
Kagoshima, H., Ohnishi, H., Yamamoto, R., Yasumoto, A., Tona, Y., Nakagawa, T., Omori, K., & Yamamoto, N. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1060-23.2023 · Cited by 7
Retinoblastoma - Genetic Counseling and Molecular Diagnosis
Houdayer, C., Gauthier‐Villars, M., Castra, L., Desjardins, L., Doz, F., & Stoppa‐Lyonnet, D. (2012) · InTech eBooks · doi:10.5772/34069 · Cited by 7
Ngugi, M. P., & Njagi, J. M. (2015) · International Journal of Current Pharmaceutical Research · Cited by 7
The two‐hit model for Wilms' tumor: Where are we 30 years later?
Strong, L. C. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10292 · Cited by 7
“Much focus continues on the function of RB and its related proteins in cell proliferation, differentiation, and cell death (for reviews see Classon and Harlow, 2002; Chau and Wang, 2003).”
BackgroundTumor suppressive pathways in the control of neurogenesis
Bartesaghi, S., & Salomoni, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1063-9 · Cited by 8
“Moreover, all Rb proteins are phosphorylated by CDKs [127, 163].”
BackgroundModeling disease in the mouse: Lessons from DNA damage response and cell cycle control genes
Adelman, C. A., Petrini, J. H. J., & Attwooll, C. L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20701 · Cited by 7
“of the pRb tumor suppressor pathway appears to be an essential step in tumor progression [Classon and Harlow, 2002].”
BackgroundAcetylation of Retinoblastoma Like Protein2 (Rb2/p130) in Tumor Tissues
Khan, Z. N., Sabir, M., Kayani, M. A., & Saeed, M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.3.2255 · Cited by 8
“The term “pocket proteins” derives from conserved pocket domain (Paggi and Giordano, 2001; Claudio et al., 2002; Cobrinik, 2005) present in all three members of the Rb family through which they bind to viral oncoproteins (Classon and Dyson, 2001; Cobrinik, 2005; Rocha-Sanchez et al., 2007).”
BackgroundInfluentialMouse Models of Inherited Cancer Syndromes
Jahid, S., & Lipkin, S. M. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.011 · Cited by 7
Buchold, G. M., Magyar, P. L., & O’Brien, D. A. (2007) · Molecular Reproduction and Development · doi:10.1002/mrd.20715 · Cited by 7
“INK4 CKIs inhibit proliferation by facilitating the downstream activities of the Rb family members to modulate transcription by members of the E2F family (Classon and Harlow, 2002).”
BackgroundWu, J., Sun, S., Li, W., Chen, Y., & Li, H. (2014) · Neuroreport · doi:10.1097/wnr.0000000000000241 · Cited by 7
An Exploration of Mutation Status of Cancer Genes in Breast Cancers
Wang, X. (2014) · Journal of Next Generation Sequencing & Applications · doi:10.4172/2469-9853.1000103 · Cited by 9
“In addition to retinoblastoma, somatic mutations in the RB1 (retinoblastoma 1) gene are associated with many other types of cancer including bladder cancer, lung cancer, breast cancer, osteosarcoma, melanoma, and leukemia [20].”
BackgroundCongenital Malformations, Perinatal Diseases, and Phacomatoses
Folkerth, R. D., & Lidov, H. G. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0949-0.00004-2 · Cited by 8
Hope in sight for retinoblastoma
Sage, J. (2007) · Nature Medicine · doi:10.1038/nm0107-30 · Cited by 8
Krause, C., Klüttermann, K., & Mauz‐Körholz, C. (2008) · PubMed · Cited by 7
Thomas, R., Prabhu, P. D. A. H., Jothi, M., Rohini, R., Sivakumar, D., Jayakumar, P. N., Devi, B. I., Satish, S., Sastry, K. V. R., & Gope, R. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-5617-0 · Cited by 7
CMF1–Rb interaction promotes myogenesis in avian skeletal myoblasts
Robertson, J. B., Zhu, T., Nasreen, S., Kilkenny, D. M., Bader, D. M., & Dees, E. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21544 · Cited by 7
“However, in addition to its important role in cell cycle control, Rb has direct regulatory roles in other cellular processes, including differentiation and apoptosis (Zacksenhaus et al., 1996; Kaelin, 1999; Novitch et al., 1999; Classon and Harlow, 2002).”
BackgroundNaturally death-resistant precursor cells revealed as the origin of retinoblastoma
Trinh, E., Denchi, E. L., & Helin, K. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.026 · Cited by 7
Genes, Respiration, Viruses, and Cancer
Seyfried, T. N. (2012) · Wiley eBooks · doi:10.1002/9781118310311.ch9 · Cited by 8
Stark, M. R. (2015) · AccessScience · doi:10.1036/1097-8542.900127 · Cited by 7
Atzori, L., Pilloni, L., Zanniello, R., Ferreli, C., & Rongioletti, F. (2020) · Journal of Cutaneous Pathology · doi:10.1111/cup.13655 · Cited by 6
“suppressor gene and its product, RBp, is involved in preventing abnormal cell growth by inhibiting cell cycle progression.(28-30) Reduced or absent expression of RBp is described in approximately 70% of all the soft tissue sarcomas and has been associated with higher proliferative activity and poor survival.”
BackgroundGu, L., Ma, G., Li, C., Lin, J., & Zhao, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.958170 · Cited by 6
“The development of RB is associated with the loss of anti-oncogene RB1, which affects the cell cycle, cellular proliferation, and apoptosis (56, 57).”
BackgroundRetinoblastoma family proteins: New players in DNA repair by non-homologous end-joining
Huang, P. H., Cook, R., Zoumpoulidou, G., Luczynski, M. T., & Mittnacht, S. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1053596 · Cited by 6
“The tumor suppressor retinoblastoma protein (RB1) is a critical component of proliferation and fate control in cells.(1,2) Heritable mutations in RB1 cause a highly penetrant predisposition to the childhood cancer retinoblastoma, combined with a substantially increased lifetime risk for other cancers.”
BackgroundGenetic Predisposition and Genetic Susceptibility
Merks, J. H. M., & Brecht, I. B. (2011) · Pediatric oncology · doi:10.1007/978-3-642-04197-6_6 · Cited by 6
Modeling Cell Cycle Control and Cancer with pRB Tumor Suppressor
Yamasaki, L. (2006) · Springer eBooks · doi:10.1007/b136682 · Cited by 7
Janeway, K. A., Gorlick, R. G., & Bernstein, M. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00022-4 · Cited by 10
Cell Size Checkpoint Control by the Retinoblastoma Tumor Suppressor Pathway
Fang, S., Reyes, C. D. L., & Umen, J. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0020167.eor · Cited by 6
Zhang, B., Chang, B., Wang, L., & Xu, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1266515 · Cited by 4
“The transcription product of the Rb gene is about 4.7 kb, and the expression product is P105-Rb, a 928 amino acid protein with a molecular weight of about 105 kDa (Classon and Harlow, 2002).”
BackgroundInfluentialMutating RBF Can Enhance Its Pro-Apoptotic Activity and Uncovers a New Role in Tissue Homeostasis
Milet, C., Rincheval‐Arnold, A., Moriéras, A., Clavier, A., Garrigue, A., Mignotte, B., & Guénal, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102902 · Cited by 7
“The Retinoblastoma gene, Rb, was first identified as the tumor suppressor gene mutated in a rare childhood eye cancer, and its product (pRb) is often functionally inactivated in many human cancers by mutation or hyperphosphorylation [1,2].”
BackgroundMechanisms of hepatocarcinogenesis in chronic hepatitis C
Mitchell, J. K., & McGivern, D. R. (2014) · Hepatic Oncology · doi:10.2217/hep.14.7 · Cited by 6
Xia, H., Wang, M., Su, X., Lv, Z., Yan, Q., Guo, X., & Liu, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.838654 · Cited by 8
“Retinoblastoma tumor suppressor protein (RB) is a pivotal regulator of the cell cycle and functionally inactive in most cancers, including prostate cancer (Classon and Harlow, 2002; Jarrard et al., 2002).”
BackgroundWilliams, C. K., Vaithiyalingam, S., Hammel, M., Pipas, J. M., & Chazin, W. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.12.014 · Cited by 5
“1B) have been implicated in transcriptional activation and several other cellular processes [6].”
BackgroundSaboo, S. S., Ramaiya, N. H., Jacene, H. A., Rainville, I. R., Diller, L., Hornick, J. L., & George, S. (2012) · Abdominal Imaging · doi:10.1007/s00261-012-9904-4 · Cited by 5
“Retinoblastoma gene (RB1), the first tumor suppressor gene to be identified, has a known association with many human malignancies, including retinoblastoma, small-cell lung carcinoma, soft tissue sarcoma (LMS in particular) and osteosarcoma [3, 4].”
BackgroundAn Overlapping Kinase and Phosphatase Docking Site Regulates Activity of the Retinoblastoma Protein
Hirschi, A., Cecchini, M. J., Steinhardt, R. C., Dick, F. A., & Rubin, S. M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.1349 · Cited by 6
Shearer, D. D., Askeland, R. W., Park, J. M., Fajardo, L. L., & Yang, L. (2012) · Proceedings in Obstetrics and Gynecology · doi:10.17077/2154-4751.1194 · Cited by 6
“retinoblastoma protein or pRB, is vital to numerous cell processes, including DNA repair, cell cycle control, DNA replication, and proliferation.(18) Cells with two altered copies of the RB1 gene produce no”
BackgroundProteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells
Seabra, L., & Warenius, H. M. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.014 · Cited by 5
Lindegaard, J. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2006.00868.x · Cited by 5
Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression
Assawarachan, S. N., Toussaint, M. J. M., Youssef, S. A., Tooten, P. C. J., & de Bruin, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150064 · Cited by 7
“Apart for their role in cell-cycle control, Rb and p53 have been implicated in many cellular processes including DNA-damage responses, DNA repair, DNA replication, cellular differentiation and apoptosis [10].”
BackgroundEffects of Ethanol on the Regulation of Cell Cycle in Neural Stem Cells
Zawada, W. M., & Das, M. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195183139.003.0012 · Cited by 5
Dysfunction of the RB Retinoblastoma Gene in Cancer
Pentimalli, F., Cito, L., & Giordano, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_8 · Cited by 5
“The three pocket proteins are differentially expressed throughout the cell cycle: RB expression is steady whereas p107 expression peaks during the S phase and p130 expression is higher in arrested cells [18, 26 ].”
BackgroundInfluentialTwo Faces of Evil: Cancer and Neurodegeneration
Curran, T., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-16602-0 · Cited by 5
Consensus transcriptional regulatory networks of coronavirus-infected human cellsPreprint
Ochsner, S. A., Pillich, R., & McKenna, N. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.24.059527 · Cited by 5
Zeng, H., Claycombe, K., & Reindl, K. M. (2015) · The FASEB Journal · doi:10.1096/fasebj.29.1_supplement.752.4 · Cited by 4
Goetsch, P. D., & Strome, S. (2022) · Genetics · doi:10.1093/genetics/iyac073 · Cited by 7
Schaal, D. L., Amucheazi, A. A., Jones, S. C., Nkadi, E. H., & Scott, R. S. (2024) · Journal of Virology · doi:10.1128/jvi.00995-24 · Cited by 4
A Strategy for Direct Chemical Activation of the Retinoblastoma Protein
Pye, C. R., Bray, W. M., Brown, E. R., Burke, J. R., Lokey, R. S., & Rubin, S. M. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00011 · Cited by 4
Context dependent roles for RB-E2F transcriptional regulation in tumor suppression
Thwaites, M. J., Cecchini, M. J., Passos, D. T., Zakirova, K., & Dick, F. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0203577 · Cited by 5
Mutations in the acetylation hotspots of Rbl2 are associated with increased risk of breast cancer
Ullah, F., Khurshid, N., Fatimi, Q., Loidl, P., & Saeed, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266196 · Cited by 5
BISBENZOXAZOLE DERIVATIVES HAD ANTI-PROLIFERATIVE EFFECT ON HUMAN CANCER CELLS
Ayaz, F., Isse, Q. A., Kheeree, R., Ersan, R. H., & Algül, Ö. (2019) · Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji · doi:10.18036/estubtdc.598863 · Cited by 4
Lynch, J. P., & Rustgi, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00080-4 · Cited by 4
Selecting the Right Targets for Cancer Therapy
Bronchud, M. H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_1 · Cited by 6
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
Kondo, T. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611009060471 · Cited by 4
“Retinoblastoma (Rb) is another essential tumor suppressor protein that regulates the G1 checkpoint [69].”
BackgroundVolk, A. K., Mitchell, E. B., Thomas, B. C., Runke, C., Essendrup, A. A., Kotzer, K. E., Deyle, D. R., Coon, L. M., Pruthi, R. K., Oglesbee, D., et al. (2016) · Springer eBooks · doi:10.1007/978-3-319-23380-2_13 · Cited by 4
Naik, K. A. P., Kethavath, S. N., Rosangzula, K., Saikrishna, J., Sangeetha, R., Patlolla, R. R., Chandgude, A. H., & Banoth, L. (2026) · Springer eBooks · doi:10.1007/978-981-95-5071-5_12 · Cited by 3
Molecular Mechanisms of Oncogenesis
Thakur, K., Sharma, S., Kumar, V., & Kumar, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-3746-2_6 · Cited by 3
Tian, X., Chen, L., Chen, Y., He, Y., & Zhang, N. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2465852 · Cited by 6
“Binding of CDK4/6 to cyclin D1 induces phosphorylation of the retinoblastoma (Rb) tumor suppressor protein, releasing its inhibitory effect and thereby providing the starting signal for cell division [8–10].”
Increasing RB1 Expression by Targeting EZH2 in Triple‐Negative Breast Cancer
Yang, R., Fei, L., Xue, Y., Zhang, Y., Hu, Q., Guo, L., Wei, Y., & Wu, Q. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70384 · Cited by 3
The Evolutionary Origins of Cancer and of Its Control by Immune Policing and Genetic Suppression
Nunney, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00001-6 · Cited by 8
Posttranslational Modifications Associated With Cancer and Their Therapeutic Implications
Bansal, A. K., Singh, L. R., & Kamli, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00009-6 · Cited by 3
Li, Y., Gao, W., Cai, X., Jin, A., Shen, J., Zhang, Y., Chen, Y., Hu, B. Q., Zeng, T., Yu, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722814 · Cited by 3
“RB is closely related to two genes in mice and humans (p107 and 130, which are not commonly mutated in tumors) (34).”
BackgroundChen, Y., Peng, J., & Cao, S. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v21i7.3 · Cited by 4
“Retinoblastoma is a deadly human cancer which causes high mortality [14].”
BackgroundHansen, M. F. (2009) · Springer eBooks · doi:10.1007/978-1-84882-019-7_2 · Cited by 3
“RB1 plays a role in many cell processes, including cell cycle regulation [99, 281], DNA damage response and repair [69, 144, 145, 310], DNA replication [210], apoptosis [32, 99, 107], and differentiation [38, 45, 148, 168].”
BackgroundA novel form of pRb expressed during normal myelopoiesis and in tumour‐associated macrophages
Liu, H., Thompson, A. M., & Macleod, K. F. (2005) · Cell Proliferation · doi:10.1111/j.1365-2184.2005.00326.x · Cited by 4
“The retinoblastoma (Rb) tumour suppressor gene is required for coordinating cell cycle exit, with tissue-specific gene expression occurring during terminal differentiation (Classon & Harlow 2002; Liu et al .”
BackgroundInteraction Between the Retinoblastoma Protein and Protein Phosphatase 1 During the Cell Cycle
Berndt, N., & Ludlow, J. W. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:017 · Cited by 6
Cell Cycle Regulators in Stem Cells
Cheng, T., & Scadden, D. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409503-8.00008-1 · Cited by 3
Mutational Characterization of Colorectal Cancer from Korean Patients with Targeted Sequencing
Lee, J., Choi, S., Jung, D.-H., Jung, Y., Kim, J. H., Jung, S., & Lee, W. S. (2021) · Journal of Cancer · doi:10.7150/jca.61324 · Cited by 3
“045), which have been reported to be associated with various cancers as tumor suppressors [19-22], showed high frequencies of mutations in younger patients (U50).”
BackgroundLindegaard, J. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2006.00907.x · Cited by 3
G1 length dictates H3K27me3 landscapesPreprint
Trouth, A., Ravichandran, K., Gafken, P. R., Martire, S., Boyle, G. E., Veronezi, G. M. B., La, V. E., Namciu, S. J., Banaszynski, L. A., Sarthy, J. F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.05.570186 · Cited by 3
“Inactivation of retinoblastoma protein (Rb) and cyclin-dependent kinase inhibitor 2A (CDKN2A) occurs frequently in cancer [18, 19].”
A transcriptional regulatory atlas of coronavirus infection of human cellsPreprint
Ochsner, S. A., Pillich, R., & McKenna, N. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.6084/m9.figshare.c.4949427 · Cited by 3
Hu, Y., Ying, H., & Xu, Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.017 · Cited by 2
“Although Rb1 is a well-known tumor suppressor gene and inhibits cell proliferation through the E2F family of transcription factors, new roles for Rb were found as a key regulator of cellular senescence, a homeostasis balance maintainer in tissues and an apoptosis suppressor [27–30].”
BackgroundCell Cycle, DNA Replication, Centrosomes, Centrioles and Cell Division
Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_15 · Cited by 4
miR-199a-3p suppresses Vldlr expression to promote cardiomyocyte proliferation
Jiang, R., Pei, L., Zhang, H., He, F., Min, Y., Li, X., & Wei, K. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024240 · Cited by 2
“The activity of E2F is tightly regulated by the retinoblastoma protein (RB1) [26], as phosphor - ylation of RB1 releases E2F from its sequestration and activates the transcriptional activity of E2F, leading to increased expression of E2F targets, including cell cycle genes [27].”
Laver, N., Sitko, K., Duker, J. S., & Farhat, N. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04711-0 · Cited by 2
Malignant Gliomas: Role of E2F1 Transcription Factor
Alonso, M. M., Fueyo-Margareto, J., & Gomez‐Manzano, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0344-5_10 · Cited by 2
“Rb was found to be an important target of oncoproteins that are expressed by DNA tumor viruses, such as adenovirus E1A, simian virus 40 T antigen, and the E7 proteins of human papillomaviruses ( Classon and Harlow, 2002 ).”
BackgroundMarx, M., Lebuhotel, C., Laugier, D., Chapelle, A., Calothy, G., & Saule, S. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.015 · Cited by 2
TP53 et RB collaborent dans le développement des rétinoblastomes humains
Ayrault, O., Zindy, F., & Roussel, M. F. (2007) · médecine/sciences · doi:10.1051/medsci/2007234356 · Cited by 2
“> En 2005-2006, la recherche sur les cellules souches embryonnaires (ES) a été marquée par deux avancées technologiques majeures pouvant avoir un impact en thérapie cellulaire (d’autres avancées fondamentales dans ce domaine des cellules ES ont été traitées par ailleurs récemment dans Médecine/Sciences) [1-3].”
BackgroundThe Stem Cell Hypothesis of Aging
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.108 · Cited by 2
Multiple molecular interactions redundantly contribute to RB-mediated cell cycle control
Thwaites, M. J., Cecchini, M. J., Talluri, S., Passos, D. T., Carnevale, J., & Dick, F. A. (2017) · Cell Division · doi:10.1186/s13008-017-0029-6 · Cited by 3
RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report
Gelli, E., Fallerini, C., Valentino, F., Giliberti, A., Castiglione, F., Laschi, L., Palmieri, M., Fabbiani, A., Tita, R., Mencarelli, M. A., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01467 · Cited by 2
“RB1 (#MIM 614041) is the first characterized and most studied tumor suppressor gene (6, 7).”
BackgroundTransgenic and Genetic Animal Models
Keri, R. A., & Siegel, R. E. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00085-1 · Cited by 2
Cell Cycle Regulators in Stem Cells
Cheng, T., & Scadden, D. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00009-3 · Cited by 2
Metadata
- Authors
- Classon, M., & Harlow, E.
- Affiliations
- Harvard University (US)
- ORCID
- Classon, Marie
- Venue
- Nature Reviews Cancer
- Published
- 2002-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 910-917
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1998492363
- Cited by
- 738
- References
- 133
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 20 · 2021: 18 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 28 · 2016: 24 · 2015: 32 · 2014: 35 · 2013: 23 · 2012: 42
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma protein, RB1, tumour suppressor, cell proliferation, cell differentiation, cell survival, Rb family proteins, protein redundancy, knockout mice, development (biology), cancer
- MeSH terms
- Animals, Cell Division, Humans, Nuclear Proteins, Phenotype, Phosphoproteins, Proteins, Retinoblastoma, Signal Transduction, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.